<br /><strong>【相关论着】</strong> <br />▶<a href="http://www.angle.com.tw/book.asp?BKID=7436" target="_blank">专利法之理论与实用／刘国赞</a> <br />▶<a href="http://www.angle.com.tw/book.asp?BKID=6696" target="_blank">台湾专利法制与判决实证／刘尚志 主编</a> <br />▶<a href="http://www.angle.com.tw/book.asp?BKID=7050" target="_blank">专利分析及运用概论：创意、发明、专利／刘容生 主编</a> <br />▶<a href="http://www.angle.com.tw/book.asp?BKID=8328" target="_blank">知识产权法／谢铭洋</a> <br />更多相关图书论着请至【元照网络书店】：<a href="http://www.angle.com.tw/layer.asp?bkid_1=3410&KindID3=3460" target="_blank">http://www.angle.com.tw/message.asp</a> <br />
<div><br /></div>
<div><span style="font-weight: bold;">【内容简介】</span> </div>
<div>主持人：冯震宇／政治大学法律学院教授 </div>
<div><br /></div>
<div>讲题一：FORUM SELECTION IN HATCH-WAXMAN ACTIONS </div>
<div>报告人：邱冠勋／明富智财管理顾问有限公司资深顾问 </div>
<div>《讲 纲》 </div>
<div>(1) Branded Drug </div>
<div>(2) ANDA </div>
<div>(3) Jurisdiction </div>
<div>(4) Latest Case Law </div>
<div>(5) Proposed Arguments </div>
<div><br /></div>
<div>讲题二：Navigating the Biosimilar Regulatory Framework </div>
<div>报告人：Kevin E. Warner／Winston & Strawn,LLP律师 </div>
<div>《讲 纲》 </div>
<div>(1) Biosimilars vs. Generic Drugs </div>
<div>(2) The "Patent Dance" </div>
<div>(3) "Phase Two" Patents </div>
<div>(4) Other Pending Biosimilar Cases </div>
<div>(5) Recent U.S. Supreme Court Cases, Developments and Trends</div>
